Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Jason Zemansky's Stock Ratings
B of A Securities Analyst
Jason Zemansky is an analyst at B of A Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/23/2025
Overall Average Return
29.5%
Smart Score
Overall Average Return Percentile
88th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 04/15/2025 | CYTK | Buy Now | Cytokinetics | $38.00 | 42.11% | Jason Zemansky74% | $62 → $54 | Maintains | Neutral | Get Alert |
| 03/20/2025 | INSM | Buy Now | Insmed | $70.80 | 35.59% | Jason Zemansky74% | $92 → $96 | Maintains | Buy | Get Alert |
| 02/19/2025 | RCUS | Buy Now | Arcus Biosciences | $8.28 | 105.31% | Jason Zemansky74% | $22 → $17 | Maintains | Neutral | Get Alert |
| 11/22/2024 | KURA | Buy Now | Kura Oncology | $6.37 | 355.26% | Jason Zemansky74% | $36 → $29 | Maintains | Buy | Get Alert |
| 10/09/2024 | INSM | Buy Now | Insmed | $70.80 | 21.47% | Jason Zemansky74% | $84 → $86 | Maintains | Buy | Get Alert |
| 08/15/2024 | SNDX | Buy Now | Syndax Pharmaceuticals | $13.00 | 138.46% | Jason Zemansky74% | $30 → $31 | Maintains | Buy | Get Alert |
| 08/09/2024 | RCUS | Buy Now | Arcus Biosciences | $8.28 | 177.78% | Jason Zemansky74% | $24 → $23 | Maintains | Neutral | Get Alert |
| 07/30/2024 | SNDX | Buy Now | Syndax Pharmaceuticals | $13.00 | 130.77% | Jason Zemansky74% | $31 → $30 | Maintains | Buy | Get Alert |
| 07/05/2024 | INSM | Buy Now | Insmed | $70.80 | 17.23% | Jason Zemansky74% | $83 → $83 | Maintains | Buy | Get Alert |
| 06/28/2024 | INSM | Buy Now | Insmed | $70.80 | 17.23% | Jason Zemansky74% | $62 → $83 | Maintains | Buy | Get Alert |
| 06/20/2024 | ESPR | Buy Now | Esperion Therapeutics | $0.95 | 163.16% | Jason Zemansky74% | $2.9 → $2.5 | Downgrade | Neutral → Underperform | Get Alert |
| 05/29/2024 | INSM | Buy Now | Insmed | $70.80 | -12.43% | Jason Zemansky74% | $40 → $62 | Maintains | Buy | Get Alert |
| 05/28/2024 | INSM | Buy Now | Insmed | $70.80 | -43.5% | Jason Zemansky74% | $40 → $40 | Maintains | Buy | Get Alert |
| 05/23/2024 | CYTK | Buy Now | Cytokinetics | $38.00 | 57.89% | Jason Zemansky74% | $70 → $60 | Maintains | Neutral | Get Alert |
| 05/14/2024 | CYTK | Buy Now | Cytokinetics | $38.00 | 84.21% | Jason Zemansky74% | $75 → $70 | Maintains | Neutral | Get Alert |
| 02/23/2024 | INSM | Buy Now | Insmed | $70.80 | -43.5% | Jason Zemansky74% | $37 → $40 | Maintains | Buy | Get Alert |
| 01/30/2024 | RCUS | Buy Now | Arcus Biosciences | $8.28 | 201.93% | Jason Zemansky74% | $23 → $25 | Maintains | Neutral | Get Alert |
| 01/03/2024 | ESPR | Buy Now | Esperion Therapeutics | $0.95 | 163.16% | Jason Zemansky74% | $4 → $2.5 | Downgrade | Buy → Neutral | Get Alert |
| 12/26/2023 | ALVR | Buy Now | AlloVir | — | — | Jason Zemansky74% | $391 → $23 | Downgrade | Buy → Underperform | Get Alert |
| 10/25/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $13.00 | 123.08% | Jason Zemansky74% | → $29 | Initiates | → Buy | Get Alert |
| 09/06/2023 | INSM | Buy Now | Insmed | $70.80 | -47.74% | Jason Zemansky74% | $35 → $37 | Maintains | Buy | Get Alert |
| 09/05/2023 | RCUS | Buy Now | Arcus Biosciences | $8.28 | 177.78% | Jason Zemansky74% | $21 → $23 | Maintains | Neutral | Get Alert |
| 08/18/2023 | ALVR | Buy Now | AlloVir | — | — | Jason Zemansky74% | → $391 | Initiates | → Buy | Get Alert |
| 08/11/2023 | KURA | Buy Now | Kura Oncology | $6.37 | 386.66% | Jason Zemansky74% | → $31 | Initiates | → Buy | Get Alert |
| 07/03/2023 | RPHM | Buy Now | Reneo Pharmaceuticals | — | — | Jason Zemansky74% | → $230 | Initiates | → Buy | Get Alert |
| 06/15/2023 | ESPR | Buy Now | Esperion Therapeutics | $0.95 | 321.05% | Jason Zemansky74% | $1.25 → $4 | Upgrade | Underperform → Buy | Get Alert |
| 05/12/2023 | HOWL | Buy Now | Werewolf Therapeutics | $0.85 | 1070.41% | Jason Zemansky74% | $9 → $10 | Maintains | Buy | Get Alert |
| 03/23/2023 | HOWL | Buy Now | Werewolf Therapeutics | $0.85 | 953.37% | Jason Zemansky74% | → $9 | Reiterates | Buy → Buy | Get Alert |
| 03/16/2023 | ESPR | Buy Now | Esperion Therapeutics | $0.95 | 57.89% | Jason Zemansky74% | $8 → $1.5 | Downgrade | Neutral → Underperform | Get Alert |
| 02/27/2023 | ESPR | Buy Now | Esperion Therapeutics | $0.95 | 742.11% | Jason Zemansky74% | → $8 | Reinstates | → Neutral | Get Alert |
| 02/17/2023 | CYTK | Buy Now | Cytokinetics | $38.00 | 28.95% | Jason Zemansky74% | → $49 | Initiates | → Neutral | Get Alert |
| 01/30/2023 | HOWL | Buy Now | Werewolf Therapeutics | $0.85 | 836.33% | Jason Zemansky74% | $9 → $8 | Maintains | Buy | Get Alert |
| 11/18/2022 | RCUS | Buy Now | Arcus Biosciences | $8.28 | 298.55% | Jason Zemansky74% | → $33 | Initiates | → Neutral | Get Alert |
| 11/18/2022 | INSM | Buy Now | Insmed | $70.80 | -44.92% | Jason Zemansky74% | → $39 | Initiates | → Buy | Get Alert |
| 02/22/2022 | FIXX | Buy Now | Homology Medicines | — | — | Jason Zemansky74% | $450 → $162 | Maintains | Buy | Get Alert |
| 12/13/2021 | ALLK | Buy Now | Allakos | $0.33 | 47213.8% | Jason Zemansky74% | $145 → $155 | Maintains | Buy | Get Alert |
| 09/10/2021 | HOWL | Buy Now | Werewolf Therapeutics | $0.85 | 2943.07% | Jason Zemansky74% | → $26 | Initiates | → Buy | Get Alert |
| 01/15/2021 | ALLK | Buy Now | Allakos | $0.33 | 44161.29% | Jason Zemansky74% | → $145 | Initiates | → Buy | Get Alert |
